LINDA CHENG: Open Payments
NPI 1831490770 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 27 payments from 7 companies in 2025. Trend: 2023 $428 · 2024 $401 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 20 | $295 |
| Cumberland Pharmaceuticals, Inc. | 1 | $49 |
| Lilly USA, LLC | 2 | $39 |
| PFIZER INC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Novo Nordisk Inc | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: Kerendia, KRISTALOSE, JARDIANCE, TRUMENBA, FARXIGA, Rybelsus, REPATHA.
Industry payments across TX — which companies pay providers there.
